95.23 - 97.14
55.47 - 103.81
1.63M / 1.81M (Avg.)
55.57 | 1.74
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-11.91%
Negative revenue growth while FSM stands at 0.00%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-13.92%
Negative gross profit growth while FSM is at 0.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
-16.76%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-16.76%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-10.50%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-16.67%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-18.18%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
1.61%
Slight or no buybacks while FSM is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
1.64%
Diluted share reduction more than 1.5x FSM's 74.11%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
-13.76%
Negative OCF growth while FSM is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-13.76%
Negative FCF growth while FSM is at 0.00%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
156.85%
10Y CAGR of 156.85% while FSM is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
-43.56%
Negative 5Y CAGR while FSM stands at 0.00%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
90.09%
3Y CAGR of 90.09% while FSM is zero. Bruce Berkowitz would see if small gains can accelerate to a more decisive lead.
No Data
No Data available this quarter, please select a different quarter.
3232.53%
OCF/share CAGR of 3232.53% while FSM is zero. Bruce Berkowitz would see if modest momentum can translate into a bigger competitive lead.
785.71%
3Y OCF/share CAGR of 785.71% while FSM is zero. Bruce Berkowitz might see if small gains can expand into a broader advantage.
No Data
No Data available this quarter, please select a different quarter.
2933.79%
Positive 5Y CAGR while FSM is negative. John Neff might view this as a strong mid-term relative advantage.
658.94%
Positive short-term CAGR while FSM is negative. John Neff would see a clear advantage in near-term profit trajectory.
698.75%
10Y equity/share CAGR above 1.5x FSM's 329.12%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
729.85%
5Y equity/share CAGR above 1.5x FSM's 329.12%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
1036.77%
3Y equity/share CAGR above 1.5x FSM's 329.12%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-10.03%
Firm’s AR is declining while FSM shows 101.35%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
No Data
No Data available this quarter, please select a different quarter.
3.87%
Similar asset growth to FSM's 4.02%. Walter Schloss finds parallel expansions or investment rates.
2.31%
Under 50% of FSM's 17.08%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-46.62%
We cut SG&A while FSM invests at 1305.37%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.